E.E. Geduld’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$171K Sell
20,000
-5,000
-20% -$42.8K 0.1% 90
2016
Q3
$206K Buy
25,000
+10,000
+67% +$83.9K 0.21% 90
2016
Q2
$121K Hold
15,000
0.16% 97
2016
Q1
$101K Sell
15,000
-10,000
-40% -$65.8K 0.14% 97
2015
Q4
$197K Sell
25,000
-5,000
-17% -$36.6K 0.12% 89
2015
Q3
$172K Sell
30,000
-10,000
-25% -$61.9K 0.16% 107
2015
Q2
$216K Hold
40,000
0.13% 164
2015
Q1
$187K Hold
40,000
0.12% 162
2014
Q4
$167K Sell
40,000
-5,000
-11% -$23K 0.09% 149
2014
Q3
$234K Buy
45,000
+35,000
+350% +$180K 0.17% 126
2014
Q2
$33K Buy
+10,000
New +$33.2K 0.02% 259

Other funds holding NEO

E.E. Geduld's NEO Position: Q4 2016 in Review

E.E. Geduld reduced its NeoGenomics (NEO) stake by 20% in Q4 2016, selling an estimated $42.8K and leaving 20,000 shares worth $171K. The position accounts for 0.1% of the portfolio, ranked #90.

E.E. Geduld first reported a position in NEO in Q2 2014 and has held it in 11 quarters since. The position peaked at $234K in Q3 2014. 143 funds tracked by Wall St. Rank hold NEO as of Q4 2016.

  • E.E. Geduld held 20,000 shares of NeoGenomics worth $171K as of Q4 2016.
  • E.E. Geduld sold 5,000 NeoGenomics shares in Q4 2016, an estimated $42.8K.
  • NeoGenomics made up 0.1% of E.E. Geduld's portfolio in Q4 2016, its #90 holding.
  • E.E. Geduld first reported a position in NeoGenomics in Q2 2014 and has held it in 11 quarters since.
  • E.E. Geduld's NeoGenomics position peaked at $234K in Q3 2014.
  • 143 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2016.

Based on E.E. Geduld's 13F filing for Q4 2016, filed 8 Feb 2017.